Last updated: April 25, 2026
India Patent IN10584DEN2014: What Is Claimed and How the Landscape Is Shaped
What does IN10584DEN2014 cover at the claim level?
No claim text, claim set, or independent/dependent claim structure is present in the information available in this chat. Without access to the published specifications and claims for IN10584DEN2014, a complete and accurate claim-scope analysis cannot be produced.
What is the patent scope implied by the available bibliographic data?
No bibliographic fields (assignee, title, publication number, filing date, priority date, IPC/CPC class, application status, prosecution history, or claim categories) are provided here. Without those elements, the scope cannot be tied to claim limitations or construed against likely relevant prior art.
How does the patent landscape for India around this filing typically look?
A credible “landscape” requires, at minimum, identification of:
- The drug substance and indication(s)
- The molecule’s salts/polymorphs and dosage forms
- The claimed novelty type (compound, composition, use, process, formulation, crystal form, polymorph, or method)
- The priority chain and whether there are family members in other major jurisdictions
None of these are available in the current input, so the landscape cannot be mapped to:
- Indian and PCT family members
- Sentences about Section 3(d) or other Indian novelty/non-obviousness hooks
- Likely challenge vectors (Form 27/28, pre-grant opposition, post-grant challenge, revocation grounds)
- Relevant prior patent families and non-patent literature
- Generics entry timing or linkage to CDSCO approvals
What can be concluded about enforceable scope in India?
No enforceability conclusions can be derived without the actual claim text and prosecution outcomes in India. Key points that would normally be verified but are not in the provided material include:
- Whether claims are directed to a specific compound versus broad genus coverage
- Whether Markush-style breadth exists
- Whether product-by-process is present
- Whether claims are limited to a particular crystal form, particle size, or process parameters
- Whether the application has been granted, refused, or is pending
- Whether the claim set was narrowed during examination
Claim-scope map (required for analysis)
Independent claims
- Not available in provided material.
Dependent claims and limitation stack
- Not available in provided material.
Variant coverage (salts, polymorphs, stereochemistry, solvates)
- Not available in provided material.
Method of treatment / medical use
- Not available in provided material.
Formulation and dosage claims
- Not available in provided material.
Process claims
- Not available in provided material.
Patent landscape build (what a complete landscape requires)
Family and territorial coverage
A landscape report for an Indian filing is usually anchored to the patent family and then expanded to India-specific events.
- Not available in provided material.
Related Indian documents
Typical landscape work cross-checks:
Relevant prior art buckets
A drug-landscape analysis usually clusters prior art into:
-
Patent families (compound and formulation)
-
Scientific literature for polymorph and solvate behavior
-
Regulatory dossiers where relevant for known substances
-
Public disclosures that can be novelty-destroying for specific claim categories
-
Not available in provided material.
Key Takeaways
- A complete and accurate analysis of scope and claims for India drug patent IN10584DEN2014 cannot be produced because the claim/specification content and bibliographic prosecution data are not present in the input.
- A defensible Indian patent landscape cannot be mapped without identification of the underlying drug substance, claimed novelty category, priority family, and claim set.
- No enforceability, novelty, inventiveness, Section 3(d) positioning, or challenge vectors can be determined from the currently available information.
FAQs
-
Is IN10584DEN2014 granted in India?
Not determinable from the provided material.
-
What molecule or indication is claimed under IN10584DEN2014?
Not determinable from the provided material.
-
Does IN10584DEN2014 claim polymorphs, salts, or solvates?
Not determinable from the provided material.
-
What are the likely invalidity grounds under Indian law for this filing?
Not determinable from the provided material.
-
Which prior patents or publications are most likely to be the key landscape blockers?
Not determinable from the provided material.
References
- (No citable sources were included in the provided material.)
